Detalhe da pesquisa
1.
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.
Nature
; 615(7950): 168-174, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36813961
2.
Diet and immune response: how today's plate shapes tomorrow's health.
Trends Immunol
; 45(1): 4-10, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37949784
3.
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Br J Cancer
; 130(2): 233-241, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37996507
4.
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
Clin Chem
; 69(3): 295-307, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36644936
5.
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(25): 3309-3319, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33993741
6.
Arc/Arg3.1 defines dendritic cells and Langerhans cells with superior migratory ability independent of phenotype and ontogeny in mice.
Eur J Immunol
; 49(5): 724-736, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30786014
7.
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
BMC Cancer
; 20(1): 503, 2020 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32487035
8.
Roles of microbiota in pancreatic cancer development and treatment.
Gut Microbes
; 16(1): 2320280, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38411395
9.
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38473353
10.
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma.
Oncol Res Treat
; 46(7-8): 320-325, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37231946
11.
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial.
J Immunother Cancer
; 11(6)2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37328285
12.
Calcium channel ß3 subunit regulates ATP-dependent migration of dendritic cells.
Sci Adv
; 9(38): eadh1653, 2023 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37729408
13.
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Front Oncol
; 13: 1272175, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37909020
14.
IL-22BP controls the progression of liver metastasis in colorectal cancer.
Front Oncol
; 13: 1170502, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37324022
15.
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis.
Oncoimmunology
; 12(1): 2269634, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37876835
16.
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer.
Front Oncol
; 12: 993611, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36605436
17.
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
JAMA Oncol
; 8(8): 1150-1158, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35737383
18.
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.
J Immunother Cancer
; 9(7)2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34315821
19.
Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches.
World J Gastroenterol
; 25(29): 3920-3928, 2019 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31413527
20.
Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling.
Front Oncol
; 9: 1559, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-32039027